<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-08-20</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39160669/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">New diabetic agents providing a glucose feast for urinary yeast - what to do?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39160669-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39161173/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Sex-related differences in self-efficacy of patients with heart failure: a pooled cross-sectional study of the German Competence Network Heart Failure</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39161173-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In patients with HF, women seemed to exhibit lower self-efficacy than men. Health-related quality of life and psychological well-being were dominant determinants of self-efficacy. Future studies should investigate the role of self-efficacy as a therapeutic target for tailored and sex-specific nursing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39161195/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">The NOTCH1 and miR-34a signaling network is affected by &lt;em&gt;TP53&lt;/em&gt; alterations in CLL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39161195-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In chronic lymphocytic leukemia (CLL), TP53 mutations or deletions on chromosome 17p lead to adverse prognosis and reduced levels of miR-34a, which targets NOTCH1. Also, hyperactivated NOTCH1 signaling is crucial for CLL progression. Here we explored the interaction between p53, miR-34a, and NOTCH1 in CLL. We investigated the effect of p53 and miR-34a on NOTCH1 signaling and expression in CLL cells with altered TP53. Our results indicate that miR-34a reduces NOTCH1 3' UTR activity but might &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39162733/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Clinical and radiological outcome of surgical hallux valgus correction: open versus minimally invasive</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39162733-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: MI surgery resulted in better patient satisfaction, fewer complications, and more precise correction of IMA values. Moreover, the duration of surgery and hospital stay were significantly lower in patients undergoing MI surgery. Further research is needed to validate these findings in controlled, prospective randomised &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39162827/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39162827-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In adults receiving VA-ECMO in ICU, a conservative compared to a liberal oxygen strategy, did not affect the number of ICU-free days to day &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39162833/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">A dendrite is a dendrite is a dendrite? Dendritic signal integration beyond the &#34;antenna&#34; model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39162833-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Neurons in central nervous systems receive multiple synaptic inputs and transform them into a largely standardized output to their target cells-the action potential. A simplified model posits that synaptic signals are integrated by linear summation and passive propagation towards the axon initial segment, where the threshold for spike generation is either crossed or not. However, multiple lines of research during past decades have shown that signal integration in individual neurons is much &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pypi.org/project/label-studio/1.13.1/">1.13.1</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/pypi-org-project-label-studio-1-13-1/">
    
    
    
    
    
      
    
    Label Studio annotation &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Ot70botGN">我这个月爱上了食堂的cheese platter。这是我最近每天的午饭。这里面有Brie，Chevre和Manchego，不知道为什么，食堂里的这三种比自己平时买的要好吃很多，一点杂...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ot70botgn/">
    
    
    
    
    
      
    
    我这个月爱上了食堂的cheese platter。这是我最近每天的午饭。这里面有Brie，Chevre和Manchego，不知道为什么，食堂里的这三种比自己平时买的要好吃很多，一点杂味都没有。这又成了不在家办公的一个理由。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·Foster City Recreation Center<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/4a994b1dgy1hsu3uxizdrj217z1h74i3.jpg%22">https://tvax3.sinaimg.cn/large/4a994b1dgy1hsu3uxizdrj217z1h74i3.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Ot7GP8q4W">DNC第一天压轴是Biden，他今晚演讲表现得非常好。显然他善于teleprompter演讲，但不善于辩论。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ot7gp8q4w/">
    
    
    
    
    
      
    
    DNC第一天压轴是Biden，他今晚演讲表现得非常好。显然他善于teleprompter演讲，但不善于辩论。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Ot86BfaRt">南京大学吴稚伟和合作者在Nature Communications发表了一篇HIV治疗抗体开发研究，报道了一种新开发的纳米体（nanobodies） - Nb457纳米体，这一纳米体来自于用CD...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ot86bfart/">
    
    
    
    
    
      
    
    南京大学吴稚伟和合作者在Nature Communications发表了一篇HIV治疗抗体开发研究，报道了一种新开发的纳米体（nanobodies） - Nb457纳米体，这一纳米体来自于用CD4-rFC免疫羊驼后产生。Nb457纳米体具有良好的体外抗病毒活性，可以低半数有效浓度（IC50）抑制各种流行亚型HIV-1病毒，其广谱性好于已上市的CD4单抗Ibalizimab。结构解析显示Nb457可以诱导CD4发生构象变化，从而阻断HIV与CD4结合。在HIV感染的NDG-HuPBL小鼠模型中，Nb457纳米体具有良好治疗效果，可以将小鼠峰值病毒载量抑制到1000拷贝以下，因此，Nb457纳米体可以作为潜在的HIV治疗手段用于HIV治疗。&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/4a994b1dgy1hsu8q9kv60j20uk6uku0x.jpg%22">https://tvax4.sinaimg.cn/large/4a994b1dgy1hsu8q9kv60j20uk6uku0x.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcBDjZb1">🔻看到有人玩到不穿衣服的狐狸了。#黑神话悟空# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcbdjzb1/">
    
    
    
    
    
      
    
    🔻看到有人玩到不穿衣服的狐狸了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcCrCied">🔻看最后的BGM，应该是有完美结局的。🔻明天如果还继续玩的话，等攻略和地图出来再回头清一清隐藏支线。🔻明天晕车就算了。#黑神话悟空# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otccrcied/">
    
    
    
    
    
      
    
    🔻看最后的BGM，应该是有完美结局的。<!-- raw HTML omitted -->🔻明天如果还继续玩的话，等攻略和地图出来再回头清一清隐藏支线。<!-- raw HTML omitted -->🔻明天晕车就算了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcDSuvlW">我可能真的不太适合这种转来转去的游戏，没小地图没有办法锁定一个北向，现在想起来都有点yue。//@腹黑兔被炸的第21个号:别放弃[泪][泪][泪]多少手残党都指望你...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcdsuvlw/">
    
    
    
    
    
      
    
    我可能真的不太适合这种转来转去的游戏，没小地图没有办法锁定一个北向，现在想起来都有点yue。//<!-- raw HTML omitted -->@腹黑兔被炸的第21个号<!-- raw HTML omitted -->:别放弃<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcEnAu9k">🔻我知道我为什么玩到后面会觉得晕车了。🔻因为脑子一直在找北，但是找不着北。🔻我是那种开导航都要锁定北面一直在上的，我受不了车的箭头视角转来转去…...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcenau9k/">
    
    
    
    
    
      
    
    🔻我知道我为什么玩到后面会觉得晕车了。<!-- raw HTML omitted -->🔻因为脑子一直在找北，但是找不着北。<!-- raw HTML omitted -->🔻我是那种开导航都要锁定北面一直在上的，我受不了车的箭头视角转来转去……<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcGjdNMe">还有阿凡提//@一李地:很多人都没干过老版本动画片《镜花缘》吧，这风格应该是致敬这部的 - 转发 @包容万物恒河水:&amp;ensp;🔻有人不相信妖精没穿衣服。🔻还亲嘴...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcgjdnme/">
    
    
    
    
    
      
    
    还有阿凡提//<!-- raw HTML omitted -->@一李地<!-- raw HTML omitted -->:很多人都没干过老版本动画片《镜花缘》吧，这风格应该是致敬这部的<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻有人不相信妖精没穿衣服。<!-- raw HTML omitted -->🔻还亲嘴呢。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hsus190mgdj21gh0sqb29.jp">https://tvax2.sinaimg.cn/large/639b1bfbly1hsus190mgdj21gh0sqb29.jp</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcL5Alnm">🔻目前我玩过的前两幕，动画的名字与剧情，和西游记第十四回中的六贼眼看喜、耳听怒、鼻嗅爱、舌尝思、意见欲、身本忧相同，恰是心中贼。十四回章名“心猿归正...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcl5alnm/">
    
    
    
    
    
      
    
    🔻目前我玩过的前两幕，动画的名字与剧情，和西游记第十四回中的六贼眼看喜、耳听怒、鼻嗅爱、舌尝思、意见欲、身本忧相同，恰是心中贼。十四回章名“心猿归正六贼无踪”也和最后的BGM《心猿归正》相符。<!-- raw HTML omitted -->🔻看来完美结局就要应在这了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcP2x1IV">🔻对了，我今天打得快还是牢洛打得快？#黑神话悟空#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcp2x1iv/">
    
    
    
    
    
      
    
    🔻对了，我今天打得快还是牢洛打得快？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcUnoCmZ">🔻不对，我想想，今天我才过了二十难，岂不是我要起码四天才能通关？🔻[哆啦A梦害怕]不能吧#黑神话悟空#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcunocmz/">
    
    
    
    
    
      
    
    🔻不对，我想想，今天我才过了二十难，岂不是我要起码四天才能通关？<!-- raw HTML omitted -->🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->不能吧<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtcVlbBRv">🔻原子之心和帕鲁开发商都发了贺图，庆祝了黑神话开游。#黑神话悟空# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcvlbbrv/">
    
    
    
    
    
      
    
    🔻原子之心和帕鲁开发商都发了贺图，庆祝了黑神话开游。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OtczNkNJs">🔻笑死，老刘 2 小时之前宣布要死扛番薯。🔻然后不更新了。🔻这么看我不菜啊。#黑神话悟空# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-otcznknjs/">
    
    
    
    
    
      
    
    🔻笑死，老刘 2 小时之前宣布要死扛番薯。<!-- raw HTML omitted -->🔻然后不更新了。<!-- raw HTML omitted -->🔻这么看我不菜啊。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ot6HBeUQg">早餐10种食物，高铁高蛋白高维生素，低糖低脂肪低淀粉。 成都·四川大学(江安校区) [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ot6hbeuqg/">
    
    
    
    
    
      
    
    早餐10种食物，高铁高蛋白高维生素，低糖低脂肪低淀粉。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->成都·四川大学(江安校区)<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d1840ee6gy1hsu2d9p4rej22eo37kx6p.jpg%22">https://tvax4.sinaimg.cn/large/d1840ee6gy1hsu2d9p4rej22eo37kx6p.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ot7SNoQMq">小区有地理优势，左右逢源，出门左转，乘公交S03，文星镇蔬菜一条街；出门右转，也是乘公交S03，白家农贸市场。今天去白家赶场，买传说中的西施豆腐，给喵奶奶做...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ot7snoqmq/">
    
    
    
    
    
      
    
    小区有地理优势，左右逢源，出门左转，乘公交S03，文星镇蔬菜一条街；出门右转，也是乘公交S03，白家农贸市场。今天去白家赶场，买传说中的西施豆腐，给喵奶奶做麻婆豆腐。喵奶奶说就在盒马买老豆腐？我说前天已经在盒马买过一次了，今天去买西施豆腐，比较一下，那家豆腐更好吃。她说买个豆腐跑那么远，有必要吗？我说我想活动一下筋骨，她说快去快回！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->成都·白家高记肥肠粉(总店)<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/d1840ee6gy1hsu7kyj4">https://tvax1.sinaimg.cn/large/d1840ee6gy1hsu7kyj4</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ot8pU5lMo">午餐两荤两素，传说中的老成都公馆菜二姨太、芦笋肉丝和麻婆豆腐、炒莲白。喵奶奶说这么多菜，吃得完？然后恍然大悟，做的两顿的？早就该这样了，顿顿饭都现做，...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ot8pu5lmo/">
    
    
    
    
    
      
    
    午餐两荤两素，传说中的老成都公馆菜二姨太、芦笋肉丝和麻婆豆腐、炒莲白。喵奶奶说这么多菜，吃得完？然后恍然大悟，做的两顿的？早就该这样了，顿顿饭都现做，太麻烦。而且找到理论依据，书上说的，8小时内不算剩菜。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->成都·四川大学(江安校区)<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OtbcIl7Q9">两年前的今天，在龙苍沟避暑，自娱自乐歌舞晚会，我们几个50后老粉红大跳“忠字舞”，场面火爆，群情亢奋，一起向“火红的年代”致敬。 - 转发 @种豆得瓜谢不谦:...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-otbcil7q9/">
    
    
    
    
    
      
    
    两年前的今天，在龙苍沟避暑，自娱自乐歌舞晚会，我们几个50后老粉红大跳“忠字舞”，场面火爆，群情亢奋，一起向“火红的年代”致敬。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@种豆得瓜谢不谦<!-- raw HTML omitted -->: 晚会很精彩，吸引了附近农家乐不少观众。大家喝庆功酒，酒不醉人人自醉，夜已深，先把压轴戏“忠字舞”发出来，和网友分享。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->种豆得瓜谢不谦的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;br &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OtbI2A3Yy">四川省社科院研究员@四川陈焕仁 老师的微博，几乎都是关于文/革的，我陆陆续续看了一些，很佩服他的坚持。我不认识陈老师，但根据他在微博中公布的1966-67年革命...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-otbi2a3yy/">
    
    
    
    
    
      
    
    四川省社科院研究员<!-- raw HTML omitted -->@四川陈焕仁<!-- raw HTML omitted --> 老师的微博，几乎都是关于文/革的，我陆陆续续看了一些，很佩服他的坚持。我不认识陈老师，但根据他在微博中公布的1966-67年革命大串联日记，他应该是文革前考入北大的学生，最资格的红卫兵，今年八十岁左右。老先生忧国忧民，最近在微博中提出应该“反思”和“反省”文/革，引发热议。我感觉陈老师很书生气。民间或非官方对文革的反思、反省从来没有停止过，而是在近年才成为敏感话题。现在网上美化文/革、意淫文革的言论甚嚣尘上，并不是国人对文/革没反思、没反省的结果，而是……什么呢？ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/tim">https://h5.sinaimg.cn/upload/2015/09/25/3/tim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OtcnME4dH">成都近日暴热，最高气温达35°C。我在地下室避暑，突然发现有入侵者，跟踪追击，准备一举歼灭之。仔细观察，哈哈，原来是儿时玩伴！ [图片][图片][图片][图片][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-otcnme4dh/">
    
    
    
    
    
      
    
    成都近日暴热，最高气温达35°C。我在地下室避暑，突然发现有入侵者，跟踪追击，准备一举歼灭之。仔细观察，哈哈，原来是儿时玩伴！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d1840ee6gy1hsurcd9tfqj22bc334e81.jpg%22">https://tvax4.sinaimg.cn/large/d1840ee6gy1hsurcd9tfqj22bc334e81.jpg&quot;</a> referrerpolicy=&ldquo;no-referr &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Ot80uoKy9">是我天真了，我以为预载120G就是完整体积[二哈]已下单2T新硬盘[二哈]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ot80uoky9/">
    
    
    
    
    
      
    
    是我天真了，我以为预载120G就是完整体积<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->已下单2T新硬盘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Ot9XmtN4a">我刚才心血来潮，查了下弈客有史以来的第一盘对局，结果发现是这盘[怒]…… [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ot9xmtn4a/">
    
    
    
    
    
      
    
    我刚才心血来潮，查了下弈客有史以来的第一盘对局，结果发现是这盘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->…… <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OtaNvBjvV">给灭火器箱充电！ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-otanvbjvv/">
    
    
    
    
    
      
    
    给灭火器箱充电！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ot8ereHIE">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.CDTV ins 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ot8erehie/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.CDTV ins <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtaQ1lZgQ">挥之不去的叔气😮💨 - 转发 @钢波Orz:&amp;ensp;久保史绪里有趣的靓女 久保绪[doge] [图片][图片][图片][图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otaq1lzgq/">
    
    
    
    
    
      
    
    挥之不去的叔气😮💨<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@钢波Orz<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->有趣的靓女 久保绪<!-- raw HTML omitted -->&lt;img alt=&quot;[doge]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/d_d">https://h5.sinaimg.cn/m/emoticon/icon/others/d_d</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbhGo9c3">做大！做强！ - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.汤浅弘章 X和乃木坂46的久保史绪里进行了对谈。虽然是第一次见面，但是她非常有礼和高尚。视频里聊了MV和...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbhgo9c3/">
    
    
    
    
    
      
    
    做大！做强！<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.汤浅弘章 X<!-- raw HTML omitted -->和乃木坂46的久保史绪里进行了对谈。虽然是第一次见面，但是她非常有礼和高尚。视频里聊了M &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbhJD2Fw">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里via.緒行記fb [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbhjd2fw/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.緒行記fb &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hsujog4atxj30u00k0ta6.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hsujog4atxj30u00k0ta6.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbhOmOVu">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 新加坡太好玩了…跟大家在一起太高兴了…很嗨。。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbhomovu/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;am">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;am</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbhVbNzc">姐姐😭 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# 姐姐发我的照片🤳🏻现在，在仙台站，开展了仙建工业桑的旗子。还有大型的旗子…😳我也想去看看...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbhvbnzc/">
    
    
    
    
    
      
    
    姐姐😭<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbhYpCxQ">嘬嘬嘬 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.08.20 21:03「呜呼呼」很可爱呢 是新服装呢 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbhypcxq/">
    
    
    
    
    
      
    
    嘬嘬嘬<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbhZqze6">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.08.20 21:02「呜呼呼」今天晚安啦！！明天会很忙碌。要好好努力喽明天见啦。晚安！祝你做...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbhzqze6/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbmYDiAq">我去！ - 转发 @白石麻衣油管更新了吗:&amp;ensp;白石麻衣#白石麻衣# 热烈如夏，前路生花祝你自由如云霓漫天在新的一年温柔不失果敢，顺遂且平安#白石麻衣# 生日快乐...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbmydiaq/">
    
    
    
    
    
      
    
    我去！<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@白石麻衣油管更新了吗<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->白石麻衣<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%99%BD%E7%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%99%BD%E7%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OtbnFu99K">太可爱了😭😭😭 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-otbnfu99k/">
    
    
    
    
    
      
    
    太可爱了😭😭😭 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Ot7Ius53U">分享图片 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ot7ius53u/">
    
    
    
    
    
      
    
    分享图片 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/Otcl56yWf">久保親姐姐拍的 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-otcl56ywf/">
    
    
    
    
    
      
    
    久保親姐姐拍的 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ot6ND8lZD">#黑神话悟空#大家都这么着急玩游戏嘛，我先上班了[doge]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ot6nd8lzd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->大家都这么着急玩游戏嘛，我先上班了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ot73pbX2f">棋手战鹰 #黑神话悟空# 竟然早上10点能起床？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ot73pbx2f/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%91%E7%A5%9E%E8%AF%9D%E6%82%9F%E7%A9%BA%23&amp;amp;extparam=%23%E9%BB%91%E7%A5%9E%E8%AF%9D%E6%82%9F%E7%A9%BA%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%BB%91%E7%A5%9E%E8%AF%9D%E6%82%9F%E7%A9%BA%23&amp;amp;extparam=%23%E9%BB%91%E7%A5%9E%E8%AF%9D%E6%82%9F%E7%A9%BA%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ot7y44UlP">井山：淡路岛打卡，刚来就把我大前辈（林汉杰）轰出去了#围棋#围棋 [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ot7y44ulp/">
    
    
    
    
    
      
    
    井山：淡路岛打卡，刚来就把我大前辈（林汉杰）轰出去了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ot8MyqXtN">棋手战鹰以后就该给这孩子玩一些她不会玩的游戏，节目效果还真挺好</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ot8myqxtn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->以后就该给这孩子玩一些她不会玩的游戏，节目效果还真挺好  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ot8RL6E0V">我还以为瑞幸周边是这个纸袋子和杯套（）是我想得太多了#黑神话悟空# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ot8rl6e0v/">
    
    
    
    
    
      
    
    我还以为瑞幸周边是这个纸袋子和杯套（）<!-- raw HTML omitted --><!-- raw HTML omitted -->是我想得太多了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#黑神话悟空#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OtbYqFbZj">发布了头条文章：《业余围棋界的巨星，菊池康郎——日本围棋百大奠基人029》 #围棋# 围棋 业余围棋界的巨星，菊池康郎——日本围棋百大奠基人029 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-otbyqfbzj/">
    
    
    
    
    
      
    
    发布了头条文章：《业余围棋界的巨星，菊池康郎——日本围棋百大奠基人029》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OtcccCrc4">发布了头条文章：《日本女子围棋联赛花名册——SENKO GROUP队主教练吉原由香里》 #围棋# 围棋 日本女子围棋联赛花名册——SENKO GROUP队主教练吉原由香里 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-otccccrc4/">
    
    
    
    
    
      
    
    发布了头条文章：《日本女子围棋联赛花名册——SENKO GROUP队主教练吉原由香里》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted -->&lt;/ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ot7Ue7aUz">久保史绪里via.CDTV ins 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ot7ue7auz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.CDTV ins <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/time">https://h5.sinaimg.cn/upload/2015/09/25/3/time</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OtaAoyxSh">久保史绪里via.緒行記fb [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-otaaoyxsh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.緒行記fb <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Otatc6xRv">久保史绪里via.汤浅弘章 X和乃木坂46的久保史绪里进行了对谈。虽然是第一次见面，但是她非常有礼和高尚。视频里聊了MV和电影等狂热的话题。请一定要看。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-otatc6xrv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.汤浅弘章 X<!-- raw HTML omitted -->和乃木坂46的久保史绪里进行了对谈。虽然是第一次见面，但是她非常有礼和高尚。视频里聊了MV和电影等狂热的话题。请一定要看。 &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hsuj50hcn5j30u01">https://tvax4.sinaimg.cn/large/006z6nxLgy1hsuj50hcn5j30u01</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Otb70qE6y">久保史绪里#shiorigram# 新加坡太好玩了…跟大家在一起太高兴了…很嗨。。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-otb70qe6y/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Otba3qU8w">久保史绪里#shiorigram# 姐姐发我的照片🤳🏻现在，在仙台站，开展了仙建工业桑的旗子。还有大型的旗子…😳我也想去看看呢，，，路过仙台站的时候希望大家...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-otba3qu8w/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shi &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Otbaf8rSP">久保史绪里#久保史绪里手机博# 2024.08.20 21:03「呜呼呼」很可爱呢 是新服装呢 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-otbaf8rsp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OtbanFgUx">久保史绪里#久保史绪里手机博# 2024.08.20 21:02「呜呼呼」今天晚安啦！！明天会很忙碌。要好好努力喽明天见啦。晚安！祝你做个好梦。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-otbanfgux/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1c4421S7zD">去山里看一只小狗，独生崽气质就是不一样，虎头虎脑又肥又可爱</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1c4421s7zd/">
    
    
    
    
    
      
    
    去山里看一只小狗，独生崽气质就是不一样，虎头虎脑又肥又可爱<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1paWpe9Eku">乃木坂46 36单MV花絮</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-20</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1pawpe9eku/">
    
    
    
    
    
      
    
    乃木坂46 36单MV花絮<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155542/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Age-Related Macular Degeneration and Its Genetic Risk: A Population-based Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155542-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In a population-based setting, we confirmed higher genetic risk to be associated with more severe AMD and identified associations with high-risk features of intermediate AMD. Conjoint analyses suggested that high-risk features and late AMD might be differentially associated with genetic architecture in AMD, such as ECM remodeling. Incorporation of genetic information such as GRSs might improve AMD risk prediction &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155847/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">TEDOVA: vaccine OSE2101 &#43;/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155847-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer is a leading cause of death from gynecological cancers worldwide. Platinum-based chemotherapy provides the cornerstone of the medical management. In first line and subsequent relapses, maintenance strategies are offered to prolong intervals between lines of chemotherapy. Current maintenance options involve bevacizumab and poly ADP-ribose polymerase inhibitors, but these lines of therapy can only be used once in the disease course. Patients in first or second platinum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155851/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">The curious physician: exploring the role of curiosity in professionalism, patient care, and well-being</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155851-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This study represents the first attempt to explore physicians' perspectives on curiosity in medicine. The findings highlight the potential importance of curiosity in shaping medical professionalism and improving patient care. However, its pursuit is hampered by the challenging working conditions faced by doctors, suggesting a need for enhanced support and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156164/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Renal and Extrarenal Phenotypes in Patients With &lt;em&gt;HNF1B&lt;/em&gt; Variants and Chromosome 17q12 Microdeletions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156164-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Patients with the 17q12del display a significantly better kidney survival than patients with other HNF1B variants; and for the latter, variants in the POU(s) DNA-binding domain lead to the poorest kidney survival. These are clinically relevant HNF1B kidney genotype-phenotype correlations that inform genetic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156554/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Prevalence and Associated Factors of Cataract, Cataract Surgery and Postoperative Outcome in an Old Population in Russia: The Ural Very Old Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156554-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Despite a relatively high prevalence of cataract surgery, this multiethnic cohort &gt;85 years of aged from Russia showed a high prevalence of cataract-related MSVI and blindness. Main causes for postoperative MSVI (prevalence: 44.6%) and blindness (prevalence: 11.7%) were AMD, glaucoma, corneal opacifications, and myopic macular degeneration. Almost all individuals aged 85+ years need cataract surgery, despite limited chance of postoperative good &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156943/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Marginal Contribution of Pathogenic &lt;em&gt;RAD51D&lt;/em&gt; Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156943-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: No pathogenic RAD51D variant was identified in the current study. Our study data suggested a negligible association of RAD51D variants with BC/OC risk in Pakistani &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157442/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">A multiparametric analysis including single-cell and subcellular feature assessment reveals differential behavior of spheroid cultures on distinct ultra-low attachment plate types</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157442-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Spheroids have become principal three-dimensional models to study cancer, developmental processes, and drug efficacy. Single-cell analysis techniques have emerged as ideal tools to gauge the complexity of cellular responses in these models. However, the single-cell quantitative assessment based on 3D-microscopic data of the subcellular distribution of fluorescence markers, such as the nuclear/cytoplasm ratio of transcription factors, has largely remained elusive. For spheroid &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157585/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Long non-coding RNAs involved in &lt;em&gt;Drosophila&lt;/em&gt; development and regeneration</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157585-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The discovery of functional long non-coding RNAs (lncRNAs) changed their initial concept as transcriptional noise. LncRNAs have been identified as regulators of multiple biological processes, including chromatin structure, gene expression, splicing, mRNA degradation, and translation. However, functional studies of lncRNAs are hindered by the usual lack of phenotypes upon deletion or inhibition. Here, we used Drosophila imaginal discs as a model system to identify lncRNAs involved in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157610/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157610-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The HOVON 104 studied bortezomib-dexamethasone induction therapy and autologous stem cell transplantation in 50 patients, of whom 35 received an autologous stem cell transplantation (ASCT). We demonstrate a 5-year overall survival (OS) of 73% and progression-free survival (PFS) of 52% for all 50 patients with a median follow-up of 61.3 months. For the 35 transplanted patients, calculated from the date of ASCT, the 5-year OS and PFS were 91% and 68%, respectively. After ASCT, the rate of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158066/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">An unbiased lncRNAs dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158066-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Multiple Myeloma (MM) is an incurable malignancy characterised by altered expression of coding and non-coding genes promoting tumour growth and drug resistance. Although the crucial role of long non-coding RNAs (lncRNAs) in MM is clearly established, the function of the non-coding RNAome, which might allow the design of novel therapeutics, is largely unknown. We performed an unbiased CRISPR-Cas9 loss-of-function screen of 671 lncRNAs in MM cells and their Bortezomib (BZB)-resistant &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158066/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240820182307&amp;v=2.18.0.post9&#43;e462414">An unbiased lncRNAs dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158066-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240820182307-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Multiple Myeloma (MM) is an incurable malignancy characterised by altered expression of coding and non-coding genes promoting tumour growth and drug resistance. Although the crucial role of long non-coding RNAs (lncRNAs) in MM is clearly established, the function of the non-coding RNAome, which might allow the design of novel therapeutics, is largely unknown. We performed an unbiased CRISPR-Cas9 loss-of-function screen of 671 lncRNAs in MM cells and their Bortezomib (BZB)-resistant &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158067/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Epigenetic Regulation of Non-canonical Menin Targets Modulates Menin Inhibitor Response in Acute Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158067-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Menin inhibitors that disrupt Menin-MLL interaction hold promise for treating specific acute myeloid leukemia subtypes, including KMT2A rearrangements (KMT2A-r), yet resistance remains a challenge. Here, through systematic chromatin-focused CRISPR screens, along with genetic, epigenetic, and pharmacologic studies in a variety of human and mouse KMT2A-r AML models, we uncover a potential resistance mechanism independent of canonical Menin-MLL targets. We show that a group of non-canonical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158067/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240820182307&amp;v=2.18.0.post9&#43;e462414">Epigenetic Regulation of Non-canonical Menin Targets Modulates Menin Inhibitor Response in Acute Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158067-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240820182307-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Menin inhibitors that disrupt Menin-MLL interaction hold promise for treating specific acute myeloid leukemia subtypes, including KMT2A rearrangements (KMT2A-r), yet resistance remains a challenge. Here, through systematic chromatin-focused CRISPR screens, along with genetic, epigenetic, and pharmacologic studies in a variety of human and mouse KMT2A-r AML models, we uncover a potential resistance mechanism independent of canonical Menin-MLL targets. We show that a group of non-canonical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158068/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158068-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The genetic background of the high prevalence red blood cell antigen AnWj has remained unresolved since its identification in 1972, despite reported associations with both CD44 and Smyd1 histone methyltransferase. Development of anti-AnWj, which may be clinically significant, is usually due to transient suppression of antigen expression, but a small number of individuals with persistent, autosomally-recessive inherited AnWj-negative phenotype have been reported. Whole exome sequencing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158068/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240820182307&amp;v=2.18.0.post9&#43;e462414">Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158068-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240820182307-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The genetic background of the high prevalence red blood cell antigen AnWj has remained unresolved since its identification in 1972, despite reported associations with both CD44 and Smyd1 histone methyltransferase. Development of anti-AnWj, which may be clinically significant, is usually due to transient suppression of antigen expression, but a small number of individuals with persistent, autosomally-recessive inherited AnWj-negative phenotype have been reported. Whole exome sequencing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158069/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">How I approach intersectionality in hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158069-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In the context of healthcare, intersectionality refers to a framework that focuses on the ways multiple axes of social inequality intersect and compound at the macro and micro levels to produce a broad range of unequal health outcomes. With the aid of tools such as the wheel of power and privilege, this framework can help identify systemic biases hidden in plain sight in the routine diagnostic, therapeutic, and prognostic paradigms used in clinical practice. Hematopoietic stem &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158069/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240820182307&amp;v=2.18.0.post9&#43;e462414">How I approach intersectionality in hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158069-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240820182307-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In the context of healthcare, intersectionality refers to a framework that focuses on the ways multiple axes of social inequality intersect and compound at the macro and micro levels to produce a broad range of unequal health outcomes. With the aid of tools such as the wheel of power and privilege, this framework can help identify systemic biases hidden in plain sight in the routine diagnostic, therapeutic, and prognostic paradigms used in clinical practice. Hematopoietic stem &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158071/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158071-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Patients with relapsed/refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) have poor outcomes compared with newly diagnosed, treatment-naïve patients. The phase 2, open-label DELPHINUS study evaluated daratumumab (16 mg/kg intravenously) plus backbone chemotherapy in children with relapsed/refractory B-cell ALL (n=7) after ≥2 relapses and children and young adults with T-cell ALL (children, n=24; young adults, n=5) or LL (n=10) after first relapse. The primary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158071/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240820182307&amp;v=2.18.0.post9&#43;e462414">Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158071-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240820182307-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Patients with relapsed/refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) have poor outcomes compared with newly diagnosed, treatment-naïve patients. The phase 2, open-label DELPHINUS study evaluated daratumumab (16 mg/kg intravenously) plus backbone chemotherapy in children with relapsed/refractory B-cell ALL (n=7) after ≥2 relapses and children and young adults with T-cell ALL (children, n=24; young adults, n=5) or LL (n=10) after first relapse. The primary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158072/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158072-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Loss of endothelial barrier function contributes to the pathophysiology of many inflammatory diseases. Coagulation factor XI (FXI) plays a regulatory role in inflammation. While activation of FXI increases vascular permeability in vivo, the mechanism by which FXI or its activated form FXIa disrupts endothelial barrier function is unknown. We investigated the role of FXIa in human umbilical vein endothelial cell (HUVEC) or human aortic endothelial cell (HAEC) permeability. The expression &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158072/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240820182307&amp;v=2.18.0.post9&#43;e462414">Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158072-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240820182307-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Loss of endothelial barrier function contributes to the pathophysiology of many inflammatory diseases. Coagulation factor XI (FXI) plays a regulatory role in inflammation. While activation of FXI increases vascular permeability in vivo, the mechanism by which FXI or its activated form FXIa disrupts endothelial barrier function is unknown. We investigated the role of FXIa in human umbilical vein endothelial cell (HUVEC) or human aortic endothelial cell (HAEC) permeability. The expression &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158135/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Table Stakes for Equity - Consumer Demographic Data at a State-Based Marketplace</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158135-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158135/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240820182306&amp;v=2.18.0.post9&#43;e462414">Table Stakes for Equity - Consumer Demographic Data at a State-Based Marketplace</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158135-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240820182306-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158136/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158136-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158136/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240820182306&amp;v=2.18.0.post9&#43;e462414">Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158136-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240820182306-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158139/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Transforming Narratives of Gun Violence</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158139-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158139/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240820182306&amp;v=2.18.0.post9&#43;e462414">Transforming Narratives of Gun Violence</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158139-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240820182306-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158143/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Academic Medical Center-Public Health Partnerships for Outbreak Response - Collaborating with Underresourced Communities</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158143-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158143/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240820182306&amp;v=2.18.0.post9&#43;e462414">Academic Medical Center-Public Health Partnerships for Outbreak Response - Collaborating with Underresourced Communities</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158143-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240820182306-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Alpha&lt;sub&gt;1&lt;/sub&gt;-Antitrypsin Deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240820182306&amp;v=2.18.0.post9&#43;e462414">Alpha&lt;sub&gt;1&lt;/sub&gt;-Antitrypsin Deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240820182306-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158146/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">An Urban Farm-Anchored Produce Prescription Program - Food as Medicine and Economic Justice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158146-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158146/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240820182306&amp;v=2.18.0.post9&#43;e462414">An Urban Farm-Anchored Produce Prescription Program - Food as Medicine and Economic Justice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158146-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240820182306-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158147/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">A Multitiered Mentorship Model - Fostering Inclusive Pathways to Health Careers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158147-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158147/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240820182306&amp;v=2.18.0.post9&#43;e462414">A Multitiered Mentorship Model - Fostering Inclusive Pathways to Health Careers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158147-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240820182306-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158218/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158218-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Autologous hematopoietic cell transplantation (AHCT) is a commonly used treatment in multiple myeloma (MM). However, real-world global demographic and outcome data are scarce. We collected data on baseline characteristics and outcomes from 61 725 patients with newly diagnosed MM who underwent upfront AHCT between 2013 and 2017 from nine national/international registries. The primary endpoint was overall survival (OS), and the secondary endpoints were progression-free survival (PFS), &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158373/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Gold Meets Selenium: Dual Activation of Selenium-Containing Propargyl Alcohols Towards the Synthesis of 2H-Chromenes and Mechanistic Insights</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158373-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Herein, we report the synthesis of seleno-substituted chromenes from selenoalkynes and phenols. In this cascade reaction, the applied gold catalyst not only functions as a p-acid, but also as a Lewis acid, enabling the propargylic substitution in the first step to connect the oxygen carbon bond. Under the optimal reaction condition a total of 26 chromenes were accessible by this modular access. During scale up experiments, the hydrolysis of the vinylselenium substructure to the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158599/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158599-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Results of this study indicate that NOACs may offer a favorable risk-benefit profile for patients with concomitant indication for anticoagulation therapy following &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158601/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Challenging the status quo: A scoping review of value-based care models in cardiology and electrophysiology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158601-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: New VBHC models have the potential to improve the care process and patient experience while optimizing the costs. The implementation of this model has been insufficient mainly because it requires substantial changes in the existing infrastructures and local organization, the need to track adherence to guidelines and the evaluation of the quality of life improvement and patient satisfaction, among &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">The Use of a Comprehensive Concept of Capability for Wellbeing Assessment: A Best-Fit Framework Synthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Developing an instrument with the capability approach can be challenging, since the capability concept of Sen is ambiguous concerning the burdens that people experience whilst achieving their capabilities. A solution is to develop instruments with a comprehensive concept of capability, such as the concept of &lsquo;option-freedom&rsquo;. This study aims to develop a theoretical framework for instrument development with the concept of option-freedom. A best-fit framework synthesis was conducted with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158696/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Chemigenetic Far-Red Labels and Ca&lt;sup&gt;2&#43;&lt;/sup&gt; Indicators Optimized for Photoacoustic Imaging</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158696-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Photoacoustic imaging is an emerging modality with significant promise for biomedical applications such as neuroimaging, owing to its capability to capture large fields of view deep inside complex scattering tissue. However, widespread adoption of this technique has been hindered by a lack of suitable molecular reporters for this modality. In this work, we introduce chemigenetic labels and calcium sensors specifically tailored for photoacoustic imaging, using a combination of synthetic dyes &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158736/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Erratum zu: Kardiale Biomarker vor nicht-kardiochirurgischen Eingriffen</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158736-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158743/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">VEGFD signaling balances stability and activity-dependent structural plasticity of dendrites</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158743-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mature neurons have stable dendritic architecture, which is essential for the nervous system to operate correctly. The ability to undergo structural plasticity, required to support adaptive processes like memory formation, is still present in mature neurons. It is unclear what molecular and cellular processes control this delicate balance between dendritic structural plasticity and stabilization. Failures in the preservation of optimal dendrite structure due to atrophy or maladaptive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158743/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">VEGFD signaling balances stability and activity-dependent structural plasticity of dendrites</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158743-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mature neurons have stable dendritic architecture, which is essential for the nervous system to operate correctly. The ability to undergo structural plasticity, required to support adaptive processes like memory formation, is still present in mature neurons. It is unclear what molecular and cellular processes control this delicate balance between dendritic structural plasticity and stabilization. Failures in the preservation of optimal dendrite structure due to atrophy or maladaptive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158893/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158893-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: These findings show that placing nicardipine release implants during microsurgical aneurysm repair can provide safe and effective prevention of moderate to severe aVS after aSAH. A phase 3 clinical trial to investigate the effect of nicardipine implants on clinical outcome may be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158893/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158893-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: These findings show that placing nicardipine release implants during microsurgical aneurysm repair can provide safe and effective prevention of moderate to severe aVS after aSAH. A phase 3 clinical trial to investigate the effect of nicardipine implants on clinical outcome may be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Evaluating and Enhancing the Fitness-for-Purpose of Electronic Health Record Data: Qualitative Study on Current Practices and Pathway to an Automated Approach Within the Medical Informatics for Research and Care in University Medicine Consortium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The study identifies gaps between current practices in MIRACUM DICs and existing recommendations, offering insights into the complexities of assessing and reporting clinical data fitness. Additionally, a tripartite modular framework for fitness-for-purpose assessment was introduced to streamline the forthcoming implementation. It provides valuable input for developing and integrating an automated solution across multiple locations. This may include statistical comparisons &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Evaluating and Enhancing the Fitness-for-Purpose of Electronic Health Record Data: Qualitative Study on Current Practices and Pathway to an Automated Approach Within the Medical Informatics for Research and Care in University Medicine Consortium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The study identifies gaps between current practices in MIRACUM DICs and existing recommendations, offering insights into the complexities of assessing and reporting clinical data fitness. Additionally, a tripartite modular framework for fitness-for-purpose assessment was introduced to streamline the forthcoming implementation. It provides valuable input for developing and integrating an automated solution across multiple locations. This may include statistical comparisons &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159098/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Orders of Magnitude Improved Cyclotron-Mode Cooling for Nondestructive Spin Quantum Transition Spectroscopy with Single Trapped Antiprotons</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159098-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We demonstrate efficient subthermal cooling of the modified cyclotron mode of a single trapped antiproton and reach particle temperatures T_{+}=E_{+}/k_{B} below 200 mK in preparation times shorter than 500 s. This corresponds to the fastest resistive single-particle cyclotron cooling to subthermal temperatures ever demonstrated. By cooling trapped particles to such low energies, we demonstrate the detection of antiproton spin transitions with an error rate &lt;0.000 023, more than 3 orders &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159117/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Observation of Strong Nuclear Suppression in Exclusive J/ψ Photoproduction in Au&#43;Au Ultraperipheral Collisions at RHIC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159117-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We report a measurement of exclusive J/ψ and ψ(2s) photoproduction in Au+Au ultraperipheral collisions at sqrt[s_{NN}]=200 GeV using the STAR detector. For the first time, (i) the ψ(2s) photoproduction in midrapidity at the Relativistic Heavy-Ion Collider has been experimentally measured; (ii) nuclear suppression factors are measured for both the coherent and incoherent J/ψ production. At average photon-nucleon center-of-mass energy of 25.0 GeV, the coherent and incoherent J/ψ cross sections &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159219/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Vertical implantable collamer lens as a novel method to increase rotational stability</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159219-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Toric ICL vertical implantation showed good rotational stability, and appropriate visual acuity correction results with relatively low vaulting. This procedure therefore presents an effective novel method that could replace horizontal toric ICL &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159243/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Cardiovascular-Kidney-Metabolic Syndrome: Association with Adverse Events After Major Noncardiac Surgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159243-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The newly defined CKM syndrome is associated with increased morbidity and mortality after non-cardiac surgery. Thus, cardiovascular, renal, and metabolic disorders should be regarded in mutual context in this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159365/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Impact of the Novel MRI Contrast Agent Gadopiclenol on Radiotherapy Decision Making in Patients With Brain Metastases</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159365-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Gadopiclenol-enhanced MRI improved BM detection and characterization, with a direct impact on radiotherapy treatment decision between WBRT and SRS. Additionally, a more exact target delineation and planning could be performed with gadopiclenol. A prospective evaluation in a larger cohort of patients is required to confirm these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159641/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Male hypogonadism: pathogenesis, diagnosis, and management</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159641-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Organic male hypogonadism due to irreversible hypothalamic-pituitary-testicular (HPT) pathology is easily diagnosed and treated with testosterone-replacement therapy. However, controversy surrounds the global practice of prescribing testosterone to symptomatic men with low testosterone and non-gonadal factors reducing health status, such as obesity, type 2 diabetes, and ageing (ie, functional hypogonadism), but without identifiable HPT axis pathology. Health optimisation remains &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159648/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159648-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: A standardised dose-reduction strategy has not been established for the widely used gemcitabine plus nab-paclitaxel regimen in patients with metastatic pancreatic ductal adenocarcinoma. We aimed to investigate the efficacy and tolerability of alternating treatment cycles of nab-paclitaxel-gemcitabine combination therapy and gemcitabine alone versus continuous treatment with the nab-paclitaxel-gemcitabine &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39159755/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Association between right heart size and right ventricular output reserve in patients with pulmonary arterial hypertension</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39159755-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This study could underline that an enlargement of RA- and RV-area is associated with an impaired RV function at rest and during exercise in patients with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39160100/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Spatial-temporal analysis of climate and socioeconomic conditions on cholera incidence in Mozambique from 2000 to 2018: an ecological longitudinal retrospective study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39160100-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The derived lagged patterns can provide appropriate lead times in a climate-driven cholera early warning system that could contribute to the prevention and management of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39160148/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Structures of influenza A and B replication complexes give insight into avian to human host adaptation and reveal a role of ANP32 as an electrostatic chaperone for the apo-polymerase</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39160148-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Replication of influenza viral RNA depends on at least two viral polymerases, a parental replicase and an encapsidase, and cellular factor ANP32. ANP32 comprises an LRR domain and a long C-terminal low complexity acidic region (LCAR). Here we present evidence suggesting that ANP32 is recruited to the replication complex as an electrostatic chaperone that stabilises the encapsidase moiety within apo-polymerase symmetric dimers that are distinct for influenza A and B polymerases. The ANP32 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39160600/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240820182437&amp;v=2.18.0.post9&#43;e462414">Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer&#39;s disease and vascular dementia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39160600-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240820182437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Unlike PRS, information on SCD can be assessed more efficiently, and thus, the model including SCD can be more easily transferred to the clinical setting. Nevertheless, the two variables seem negligible if APOE ε4 carrier status is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OsXZvFUik">小区嘉年华，去年表演Lizzo，今年表演Cher。 美国·City of Foster City 子陵在听歌的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-osxzvfuik/">
    
    
    
    
    
      
    
    小区嘉年华，去年表演Lizzo，今年表演Cher。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·City of Foster City<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Ot2SPw2i4">别刀了别刀了[单身狗]//@自闭qwq:当年哪会有人对他说没关系你才20岁呢 - 转发 @炸九:&amp;ensp;补了04雅典决赛，从比赛结束之后到颁奖完回后台的接近半个小时里，王...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-ot2spw2i4/">
    
    
    
    
    
      
    
    别刀了别刀了<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@自闭qwq<!-- raw HTML omitted -->:当年哪会有人对他说没关系你才20岁呢<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@炸九<!-- raw HTML omitted -->: 补了04雅典决赛，从比赛结束之后到颁奖完回后台的接近半个小时里，王乐好像连眼睛都不会眨了😢<!-- raw HTML omitted -->赛后央视采访，记者连线报幕期间一直维持P1的姿势JPG一动不动了快二十秒，不知道在想些什么。中间被撞到背包水洒出来整个人失魂落魄到顶点，最后告别记者安慰他“王皓没关系”也一直垂着头懵懵的<!-- raw HTML omitted -->颁奖的时候，握手微笑 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OsXczn6uK">高德在欧洲可以导航自驾和步行，但没有城市公交导航功能。 - 转发 @成都冯川:&amp;ensp;高德导航还是不错，在欧洲也能用。江湖团自驾北欧那支部队，虽然有一个中国导...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-osxczn6uk/">
    
    
    
    
    
      
    
    高德在欧洲可以导航自驾和步行，但没有城市公交导航功能。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@成都冯川<!-- raw HTML omitted -->: 高德导航还是不错，在欧洲也能用。江湖团自驾北欧那支部队，虽然有一个中国导游，但仍然离不开手机导航。昨天他们三辆车，后面一辆车稍稍耽搁了一下，跟丢了前面的车，遂不得不用手机导航，忙乱中却又点错了目的地，点成了先前走过的一个休息站，结果向反方向开回去了。另外两个车只好停下来等他们，顺便照了些路边的风景。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OsXPPDTvb">喵奶奶引书上说水果只要烂了一点，就不能吃。她说你看，这个梨子是烂梨，不能吃。我说这可是新疆香梨，比四川的猕猴桃好吃。她说再好吃，也是烂梨，必须扔了。我...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-osxppdtvb/">
    
    
    
    
    
      
    
    喵奶奶引书上说水果只要烂了一点，就不能吃。她说你看，这个梨子是烂梨，不能吃。我说这可是新疆香梨，比四川的猕猴桃好吃。她说再好吃，也是烂梨，必须扔了。我说我们高中政治学习辩证唯物主义，质量互变规律，老师举的例子，就是🍎或🍐，只烂了一点点，这是量变，还可以吃；量变逐渐积累，越烂越多，最终引起质变，整个🍎或🍐彻底烂了，才不能吃——未必你忘了？她说忘了忘了，早就忘了！我说难怪你高考政治不及格，我现在教你理论联系实际——这个有黑斑点的新疆香梨，目测只是量变，还没发生质变，把烂的地方剜掉，照样可以吃。她说反正我不吃，我说趁🍐还没发生质变，我现在就去把它吃了。<!-- raw HTML omitted -->&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ot2gp2qLb">午餐主菜土豆烧牛肉，是赫鲁晓夫鼓吹的苏式共产主义生活标配。五六十年前，中苏交恶，毛主席曾赋《念奴娇·鸟儿问答》一词调侃之：“还有吃的，土豆烧熟了，再加...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ot2gp2qlb/">
    
    
    
    
    
      
    
    午餐主菜土豆烧牛肉，是赫鲁晓夫鼓吹的苏式共产主义生活标配。五六十年前，中苏交恶，毛主席曾赋《念奴娇·鸟儿问答》一词调侃之：“还有吃的，土豆烧熟了，再加牛肉。”很多人不解，按照烹饪常识，应该是牛肉烧熟了，再加土豆吧？党报权威批评家说，这是老人家讽刺苏修社会帝国主义，对外扩张，对内压迫，搞得民不聊生，其所谓“土豆烧牛肉”，是吹牛皮，土豆当家，牛肉只是点缀而已。<!-- raw HTML omitted --> 8年前今月，跟团游俄罗斯，团费不低，却天天劣质团餐，等于吃忆苦饭。问导游，咋个没有传说中的土豆烧牛肉呢？导游说呵呵，俄罗斯牛肉太贵了，不如回成都吃。其实，我最喜欢最擅长的不是土豆烧牛肉，而是清炖牛肉，尤其是牛肉汤，撒点胡椒面和香菜，可以和老母鸡汤争第一。喵奶奶说牛肉汤和鸡汤，还有鱼汤、猪棒子骨汤，都是嘌 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OsXOHmCkF">甲骨文吧 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-osxohmckf/">
    
    
    
    
    
      
    
    甲骨文吧 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OsZjSxyg5">认真工作比什么都重要 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oszjsxyg5/">
    
    
    
    
    
      
    
    认真工作比什么都重要 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Ot0tXhfj6">很好，辜位也锁定了。剩下位置不多了，大家预定要趁早啊。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ot0txhfj6/">
    
    
    
    
    
      
    
    很好，辜位也锁定了。剩下位置不多了，大家预定要趁早啊。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OsWYtkiIP">分享图片 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oswytkiip/">
    
    
    
    
    
      
    
    分享图片 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OsZdzqn5u">据说这一次烂柯杯，中国最强后援团成员申旻埈没有来？#围棋#围棋</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-oszdzqn5u/">
    
    
    
    
    
      
    
    据说这一次烂柯杯，中国最强后援团成员申旻埈没有来？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ot1Yd3ipg">嚯，13岁的新初段和吴依铭同一天生日#围棋#围棋 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ot1yd3ipg/">
    
    
    
    
    
      
    
    嚯，13岁的新初段<!-- raw HTML omitted --><!-- raw HTML omitted -->和吴依铭同一天生日<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ot3xc1nhr">刷题还是有点用#围棋#围棋 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ot3xc1nhr/">
    
    
    
    
    
      
    
    刷题还是有点用<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/lar">https://tvax2.sinaimg.cn/lar</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ot0NA8BWb">久保史绪里#shiorigram# 稍后将会出演🍩新曲『放纵日』请一定要看 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ot0na8bwb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ot0O3koOJ">久保史绪里[打call] - 转发 @乃木坂46:&amp;ensp;📸#乃木坂46GALLERY#📸[送花花]#3期生# Works[送花花]乃木坂46 #岩本莲加# #久保史绪里# #佐藤枫# #向井叶月# [...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ot0o3kooj/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ot1FYexxd">久保史绪里via.TBSCDTV&amp;SMR_info [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ot1fyexxd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->via.TBSCDTV&amp;SMR_info <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLg">https://tvax3.sinaimg.cn/large/006z6nxLg</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV11MpSecEVG">「ジャンピングジョーカーフラッシュ」 via. 掛橋沙耶香 毕业典礼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv11mpsecevg/">
    
    
    
    
    
      
    
    「ジャンピングジョーカーフラッシュ」 via. 掛橋沙耶香 毕业典礼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV15bpSe2E9z">「Out of the blue」 via. 掛橋沙耶香 毕业典礼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv15bpse2e9z/">
    
    
    
    
    
      
    
    「Out of the blue」 via. 掛橋沙耶香 毕业典礼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV16y411i7yD">【张捷财经】金价再创新高与全球猛料加持</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv16y411i7yd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV17HpSeHEe8">24.08.19 掛橋沙耶香 毕业典礼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv17hpsehee8/">
    
    
    
    
    
      
    
    24.08.19 掛橋沙耶香 毕业典礼
「４番目の光」
「ジャンピングジョーカーフラッシュ」
「I See&hellip;」
「猫舌カモミールティー」
「Out of the blue」
「キスの手裏剣」
「図書室の君へ」<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1AW421R7ia">【张捷聊三农之百七八】进一步提高城镇化，三农问题要发展中解决</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1aw421r7ia/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1ebpSe2Ei7">「キスの手裏剣」 via. 掛橋沙耶香 毕业典礼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1ebpse2ei7/">
    
    
    
    
    
      
    
    「キスの手裏剣」 via. 掛橋沙耶香 毕业典礼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1eS42197Ro">【张捷聊科技】腾讯的苹果税安卓税与消费者权益之差别</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1es42197ro/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1jnpme5Ef4">24.08.19 CDTV 后台签名 乃木坂46part</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1jnpme5ef4/">
    
    
    
    
    
      
    
    24.08.19 CDTV 后台签名 乃木坂46part<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1PNpmexEDV">乃木坂46 36th 「チートデイ」完整版 TV初披露</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1pnpmexedv/">
    
    
    
    
    
      
    
    乃木坂46 36th 「チートデイ」完整版 TV初披露<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1rLpSexEAp">「４番目の光」 via. 掛橋沙耶香 毕业典礼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1rlpsexeap/">
    
    
    
    
    
      
    
    「４番目の光」 via. 掛橋沙耶香 毕业典礼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1supSe8E5Q">「I See...」 via. 掛橋沙耶香 毕业典礼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1supse8e5q/">
    
    
    
    
    
      
    
    「I See&hellip;」 via. 掛橋沙耶香 毕业典礼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1supSe8EEM">「猫舌カモミールティー」 via. 掛橋沙耶香 毕业典礼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1supse8eem/">
    
    
    
    
    
      
    
    「猫舌カモミールティー」 via. 掛橋沙耶香 毕业典礼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

